Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer
Lisa A. Kachnic, Kathryn A. Winter, Robert J. Myerson, Michael D. Goodyear, Andre A. Abitbol, Oscar E. Streeter, Mark E. Augspurger, Tracey E. Schefter, Alan W. Katz, Barbara J. Fisher, Lauren E. Henke, Samir Narayan, Christopher H. Crane
Profundice en los temas de investigación de 'Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer'. En conjunto forman una huella única.